Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M162,450Revenue $M24,890Net Margin (%)51.7Altman Z-Score7.9
Enterprise Value $M163,927EPS $7.4Operating Margin %64.0Piotroski F-Score8
P/E(ttm)12.5Beneish M-Score-2.3Pre-tax Margin (%)62.4Higher ROA y-yY
Price/Book9.510-y EBITDA Growth Rate %--Quick Ratio2.4Cash flow > EarningsY
Price/Sales6.55-y EBITDA Growth Rate %27.2Current Ratio2.7Lower Leverage y-yN
Price/Free Cash Flow10.9y-y EBITDA Growth Rate %180ROA % (ttm)44.1Higher Current Ratio y-yY
Dividend Yield %0.4PEG0.5ROE % (ttm)93.9Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M1,470ROIC % (ttm)84.4Gross Margin Increase y-yY

Gurus Latest Trades with GILD

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GILDKen Fisher 2015-06-30 Add$97.72 - $122.21
($109.1)
$ 110.651%Add 0.26%791,630
GILDJulian Robertson 2015-03-31 Reduce-5.61%$94.91 - $107.18
($101.54)
$ 110.659%Reduce 56.64%231,511
GILDLeon Cooperman 2015-03-31 Sold Out -0.96%$94.91 - $107.18
($101.54)
$ 110.659%Sold Out0
GILDFirst Eagle Investment 2015-03-31 Reduce-0.3%$94.91 - $107.18
($101.54)
$ 110.659%Reduce 99.97%400
GILDNWQ Managers 2015-03-31 Buy 0.14%$94.91 - $107.18
($101.54)
$ 110.659%New holding113,100
GILDJohn Rogers 2015-03-31 Add0.1%$94.91 - $107.18
($101.54)
$ 110.659%Add 11.07%891,645
GILDJoel Greenblatt 2015-03-31 Add0.07%$94.91 - $107.18
($101.54)
$ 110.659%Add 9.73%1,107,732
GILDDavid Dreman 2015-03-31 Buy 0.05%$94.91 - $107.18
($101.54)
$ 110.659%New holding5,580
GILDKen Fisher 2015-03-31 Add$94.91 - $107.18
($101.54)
$ 110.659%Add 2.35%789,615
GILDRonald Muhlenkamp 2015-03-31 Reduce$94.91 - $107.18
($101.54)
$ 110.659%Reduce 0.09%218,740
GILDMario Gabelli 2015-03-31 Add$94.91 - $107.18
($101.54)
$ 110.659%Add 16.13%49,470
GILDDodge & Cox 2015-03-31 Reduce$94.91 - $107.18
($101.54)
$ 110.659%Reduce 5.76%4,250
GILDKen Heebner 2014-12-31 Sold Out -4.7%$89.45 - $114.22
($103.4)
$ 110.657%Sold Out0
GILDJulian Robertson 2014-12-31 Add1.67%$89.45 - $114.22
($103.3)
$ 110.657%Add 20.27%533,911
GILDLeon Cooperman 2014-12-31 Buy 0.96%$89.45 - $114.22
($103.54)
$ 110.657%New holding612,500
GILDFirst Eagle Investment 2014-12-31 Add0.3%$89.45 - $114.22
($103.4)
$ 110.657%Add 328672.00%1,315,088
GILDJoel Greenblatt 2014-12-31 Add0.26%$89.45 - $114.22
($103.3)
$ 110.657%Add 51.98%1,009,462
GILDRonald Muhlenkamp 2014-12-31 Add0.24%$89.45 - $114.22
($103.4)
$ 110.657%Add 6.10%218,945
GILDJohn Rogers 2014-12-31 Add0.17%$89.45 - $114.22
($103.4)
$ 110.657%Add 24.68%802,803
GILDVanguard Health Care Fund 2014-12-31 Sold Out -0.1%$89.45 - $114.22
($103.4)
$ 110.657%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GILD is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


GILD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MILLIGAN JOHN FPresident and COO 2015-07-07Sell100,000$114.44-1.41view
BISCHOFBERGER NORBERT WEVP, R&D and CSO 2015-07-07Sell70,000$118.27-4.6view
Alton Gregg HEVP, Corp & Med Affairs 2015-07-01Sell17,000$116.73-3.34view
Carter Paul RutherfordEVP Commercial Ops 2015-07-01Sell3,000$118.24-4.58view
MARTIN JOHN CChairman and CEO 2015-07-01Sell150,000$116.46-3.12view
Cogan John FrancisDirector 2015-06-26Sell27,000$120.13-6.08view
Carter Paul RutherfordEVP Commercial Ops 2015-06-18Sell10,000$120-5.97view
BISCHOFBERGER NORBERT WEVP, R&D and CSO 2015-06-15Sell70,000$117.67-4.11view
MILLIGAN JOHN FPresident and COO 2015-06-08Sell100,000$114.05-1.07view
MARTIN JOHN CChairman and CEO 2015-06-01Sell150,000$113.95-0.98view

Quarterly/Annual Reports about GILD:

News about GILD:

Articles On GuruFocus.com
shortlist Jul 19 2015 
shortlist Jul 19 2015 
shortlist Jul 19 2015 
shortlist Jul 19 2015 
shortlist Jul 19 2015 
It’s Not Too Late To Buy Gilead Sciences Jul 17 2015 
Weekly Insider Sells Highlight: GILD, AXTA, GME, DXCM Jul 14 2015 
Gilead Sciences is Still Undervalued Jul 06 2015 
Julian Robertson Discusses Greece Threat, Stocks and Apple Jun 30 2015 
Why I Am Buying Gilead Sciences Jun 30 2015 

More From Other Websites
This Healthcare Fund Thinks Large-Caps Are The Best Way To Go Jul 26 2015
[video]What to Watch in the Week Ahead: Twitter, Facebook Earnings, GDP Jul 26 2015
BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead Jul 26 2015
Gilead (GILD) to Report Q2 Earnings: Surprise in the Cards? - Analyst Blog Jul 24 2015
Street Talk: SCTY, V, BIDU & GILD Jul 24 2015
Biogen: Run Lola Run? Jul 24 2015
Countdown to health care earnings Jul 24 2015
Gilead Sciences: Still Plenty of Growth Despite 'Stagnated' Hepatitis-C Jul 24 2015
"A Significant Step Forward" for Hepatitis C Patients Seeking a Cure, after Quebec Announces Public... Jul 24 2015
Cramer's Mad Dash: Biogen's biotech blues Jul 24 2015
Bet on a Gilead Rally Jul 23 2015
Gilead Sciences Leads 3 Top-Rated Big Cap Stocks Jul 22 2015
Gilead (GILD) Presents Encouraging Data on HIV Candidate - Analyst Blog Jul 22 2015
Hedge Funds Love These 5 Big Stocks -- Should You? Jul 22 2015
A World Changing Drug Is About to be Judged Jul 21 2015
Gilead Sciences to Release Second Quarter 2015 Financial Results on Tuesday, July 28, 2015 Jul 21 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK